Pharmaceutical Technology

MARCH 6, 2023

Patients in the US and EU with recurrent or metastatic nasopharyngeal carcinoma (NPC), a subtype of head and neck squamous cell carcinoma (HNSCC), are mostly treated with a combination of chemotherapy agents in the frontline setting, such as cisplatin + gemcitabine. months for the chemotherapy arm (hazard ratio [HR]: 0.52).

Chemotherapy 52

Chemotherapy Labelling Immunity Immunization 52

Quality Matters

FEBRUARY 6, 2025

To understand monoclonal antibody drugs, its necessary to first know a little about how antibodies work in the bodys immune system. The immune system protects the body from harmful substances, microbes and abnormal cells that can cause diseases. Anything that triggers an immune response is called an antigen.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Immunity Immunization Biosimilars 52

RX Note

JULY 29, 2023

In a study published in JAMA Internal Medicine , off-label use lacking strong scientific evidence had a higher adverse drug event rate compared with on-label use. However, off-label use with strong scientific evidence had the same risk for adverse drug events as on-label use.

Labelling 40

Labelling Dosage Immunity Immunization 40

Pharmaceutical Technology

FEBRUARY 13, 2023

Surprisingly, ARV-471 has progressed to Phase III to be evaluated in a less heavily pretreated population where all patients have received CDK4/6 inhibitors, but unlike the Phase II, patients who have received Faslodex or chemotherapy for advanced disease will be excluded. with Calquence, 16% with Imbruvica, NCT02477696).

Dosage 59

Dosage Chemotherapy Compounding Immunity 59

pharmaphorum

JANUARY 26, 2022

The regulatory move applies only to trials of magrolimab given alongside Bristol-Myers Squibb’s Vidaza (azacitidine), and stems from an “imbalance” in investigator-reported serious adverse events between study arms, said the drugmaker.

Adverse Reactions 40

Adverse Reactions Chemotherapy Immunity Immunization 40

PharmaShots

FEBRUARY 13, 2023

In SM, activated mast cells release histamine and other proteins that promote allergic reactions, inflammation, and other immune responses, and people living with the disease. Traditional therapies have included multi-kinase inhibitors, chemotherapy, and symptom-directed treatments.

Chemotherapy 40

Chemotherapy Diabetes Immunity Immunization 40

PharmaShots

FEBRUARY 13, 2023

In SM, activated mast cells release histamine and other proteins that promote allergic reactions, inflammation, and other immune responses, and people living with the disease. Traditional therapies have included multi-kinase inhibitors, chemotherapy, and symptom-directed treatments.

Chemotherapy 40

Chemotherapy Diabetes Immunity Immunization 40

The Thyroid Pharmacist

NOVEMBER 4, 2022

They also concluded that patients testing with positive thyroid antibodies should be followed closely for diabetes mellitus and cardiovascular events. (1) 12) For anyone looking to support immune health, hormone balance, and metabolic health, in addition to their thyroid, this is a great option. (37-39) Brain Behav Immun.

Diabetes 98

Diabetes Dosage Compounding Immunity 98

The Thyroid Pharmacist

SEPTEMBER 20, 2024

Tegaserod : This medication was approved for IBS-C in 2002, but removed from the market in 2007 due to an increased risk of cardiovascular events. P.S. Be sure to sign up to my weekly newsletter to get a free book chapter, recipes, Thyroid Diet Starter Guide and notifications about upcoming events and my latest research. Dig Liver Dis.

Health and Personal Care Stores 77

Health and Personal Care Stores Diabetes Chemotherapy Medication Therapy Management (MTM) 77

Express Pharma

AUGUST 22, 2024

Rybrevant (amivantamab-vmjw) plus Lazcluze (lazertinib) is approved in the US as a first-line chemotherapy-free treatment for patients with EGFR-mutated advanced lung cancer. The chemotherapy-free regimen showed progression-free survival versus osimertinib. Venous thromboembolic events (VTE) were observed with the combination.

Chemotherapy 96

Chemotherapy Immunity Immunization 96

pharmaphorum

NOVEMBER 9, 2021

Lung cancer drug Opdivo administered with chemotherapy has been shown to boost survival rates in patients with resectable non-small cell lung cancer (NSCLC). The phase 3 CheckMate 816 study of Bristol-Myers Squibb’s Opdivo (nivolumab) revealed a significant improvement in event-free survival when the treatment regime is given before surgery.

Chemotherapy 59

Chemotherapy Immunity Immunization 59

European Pharmaceutical Review

NOVEMBER 24, 2022

s Libtayo ® (cemiplimab) for adults with recurrent or metastatic cervical cancer and disease progression while on or after platinum-based chemotherapy. “Libtayo ® was the first programmed cell death protein (PD)-1 inhibitor to demonstrate significant improvements in survival compared to chemotherapy in a Phase III trial.

Chemotherapy 98

Chemotherapy Immunity Immunization Adverse Reactions 98

pharmaphorum

SEPTEMBER 13, 2022

As we enter Blood Cancer Awareness month, a global event dedicated to spotlighting and supporting efforts to improve awareness, detection, and treatment of blood cancer, we take a look back in celebration of the achievements and breakthroughs that paved the way for today’s innovations. 1942 – Chemotherapy moves from trenches to treatment .

Chemotherapy 98

Chemotherapy Immunity Immunization Documentation 98

pharmaphorum

JULY 1, 2022

Top-line results from the AEGEAN trial of AZ’s PD-L1 inhibitor Imfinzi (durvalumab) plus chemotherapy given pre-surgery for resectable NSCLC tumours have revealed a significant improvement in the pathologic complete response (pCR) rate compared to chemo alone.

Chemotherapy 52

Chemotherapy Immunity Immunization 52

European Pharmaceutical Review

FEBRUARY 15, 2023

Only one late-onset immune-related adverse event (AE) occurred, 16 months post-treatment. Neoadjuvant nivolumab in combination with chemotherapy was approved by the US Food and Drug Administration (FDA) in March 2022 for lung cancer. Neoadjuvant nivolumab did not lead to surgical delays.

Chemotherapy 98

Chemotherapy Immunity Immunization 98

pharmaphorum

MARCH 16, 2021

There were no reports of graft failure, graft rejection, or graft-versus-host disease, where the body’s own immune system reject genetically modified cells. So far there has been one serious adverse event on that trial. There is only safety data available so far due the limited follow-up duration of 8.6

Chemotherapy 52

Chemotherapy Communication Immunity Immunization 52

PharmaShots

MARCH 29, 2023

It is the only drug in its class of chemotherapy and is developed from the natural substance found in a sea sponge. Indication: Type 2 Diabetes Mellitus Victoza is a non-insulin, anti-diabetic medicine used for the treatment of type 2 diabetes and to reduce the risk of cardiovascular events associated with the disease.

Biosimilars 49

Biosimilars Diabetes Chemotherapy Immunity 49

The Thyroid Pharmacist

SEPTEMBER 1, 2023

They include anesthetics, antacids, anti-anxiety medications, antibiotics, antidepressants, antifungals, cholesterol-lowering medications, anti-malarial medications, chemotherapy, appetite suppressants, arthritis medications, psychotropics, and steroids. References [1] Ghosh A, Mukherjee K, Ghosh S, Saha B. 2012;39(7):2881-2915.

Adverse Reactions 116

Adverse Reactions Compounding Chemotherapy Labelling 116

The Thyroid Pharmacist

AUGUST 26, 2022

28,29-33) Gut infections can impact nutrient absorption, metabolism, mitochondrial health, and the immune system. (28) These types of infections impact the immune system and can become triggers for autoimmunity; they can also disrupt ongoing metabolic processes. Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.

Diabetes 98

Diabetes Immunity Immunization Chemotherapy 98

LifeProNow

APRIL 19, 2023

Monitor for neurologic events after treatment with ABECMA. All events of HLH/MAS had onset within 10 days of receiving ABECMA with a median onset of 7 days (range: 4 – 9 days) and occurred in the setting of ongoing or worsening CRS. Provide supportive care and/or corticosteroids as needed. Three cases of Grade 2 HLH/MAS resolved.

Adverse Reactions 100

Adverse Reactions Vaccines Immunity Immunization 100

RX Note

FEBRUARY 23, 2023

G6PD Deficiency - Explaining G6PD Deficiency Ramadan - Medications during Ramadan fasting Adverse Drug Reactions Adverse Drug Reactions - All adverse reactions are adverse drug event Pharmacovigilance - To detect unreported ADRs Drug Allergy - Management vary based on the signs and symptoms Medicine-induced Discolouration - Red?

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

The Thyroid Pharmacist

NOVEMBER 29, 2024

is often a step that many of us must take not only to lose weight, but also to feel better, and in some cases, minimize or eliminate the attack on the immune system. The 184 Food Panel test checks for IgG (a branch of the immune system that mediates food sensitivities as well as Hashimoto’s) reactions to 184 common foods.

Health and Personal Care Stores 98

Health and Personal Care Stores Diabetes Immunity Immunization 98

RX Note

FEBRUARY 9, 2024

Adverse drug reaction 药物不良反应 - Unintended, harmful events attributed to the use of medicines. Human Immunodeficiency Virus (HIV) 人类免疫缺陷病毒 - A virus that attacks the body's immune system. Immunization 免疫接种 - A process by which a person becomes protected against a disease through vaccination. Aetiology 病因 - The cause (e.g.

Immunity 40

Immunity Immunization Communication Diabetes 40